SCHEMBL7126700

SCHEMBL7126700

NC(=O)c1ccc(-c2ccc3[nH]ccc3c2)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
PRNP P04156 1/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
AR P10275 1/20 0.47
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
NPC1 O15118 2/20 0.44
PTGS2 P35354 1/20 0.44
PSMB8 P28062 1/20 0.44
ENPP2 Q13822 1/20 0.43
PI4K2A Q9BTU6 1/20 0.43
PRKDC P78527 1/20 0.43
CYP17A1 P05093 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23091182 0.79 ERN1 (0.55) KDM4EALDH1A1HPGDNPC1PTGS2
SCHEMBL23091194 0.79 KDM4E (0.54) KDM4EPTGS2ENPP2HDAC2SRPK1
SCHEMBL30501712 0.79 KDM4E (0.54) KDM4EPTGS2ENPP2HDAC2SRPK1
SCHEMBL27565414 0.76 ALDH1A1 (0.57) KDM4EALDH1A1LMNAPRNPHPGD
SCHEMBL3377274 0.75 ALDH1A1 (0.51) KDM4EALDH1A1HPGDHSD17B10ENPP2
SCHEMBL17214988 0.74 NPC1 (0.50) CA12CA1CA2CA9NPC1
SCHEMBL13680470 0.74 NPC1 (0.50) CA12CA1CA2CA9NPC1
SCHEMBL15428851 0.72 NPC1 (0.43) ALDH1A1HPGDNPC1PTGS2PSMB8
SCHEMBL982808 0.72 CCNT1 (0.62) ARCA12CA1CA2CA9
SCHEMBL18551808 0.72 NPC1 (0.47) CA12CA1CA2CA9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311505-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ) PHARMACIA & UPJOHN COMPANY (US) 2003-05-21 EP claimed
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed
WO-2002016355-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC) ACETYLCHOLINE RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed